401k Record

Employers › Texas Oncology

Texas Oncology 401(k)

Recordkeeping fees per participant · Texas Oncology, P.A. 401(k) Plan · plan year 2024

$36.19

Higher than 54% of the 790 plans over $1B that report it.

Source

= $221,120 / 6,110
Schedule H, line 2i(3); OTH_RECORDKEEPING_FEES_AMT pos 160; filing 20251013100826NAL0002358578001, received 2025-10-13
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251013100826NAL0002358578001, received 2025-10-13

10th: $6.72median $34.2890th: $56.58

Percentiles compare this plan with the Schedule H plans over $1B in assets of the same plan year, excluding final filings; shown only where at least 50 comparable plans report the figure. Plan year 2024-01-01 to 2024-12-31, filing received 2025-10-13.

Cost and contributions

Administrative expenses excluding investment management, per participant

$38.53

10th: $9.43median $44.4790th: $97.55

Higher than 38% of the 1,045 plans over $1B that report it.

Source

= $235,420 / 6,110
derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20251013100826NAL0002358578001, received 2025-10-13
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251013100826NAL0002358578001, received 2025-10-13

Administrative expenses per participant

$50.27

10th: $24.33median $70.0390th: $174.36

Higher than 30% of the 1,076 plans over $1B that report it.

Source

= $307,150 / 6,110
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20251013100826NAL0002358578001, received 2025-10-13
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251013100826NAL0002358578001, received 2025-10-13

Administrative expenses as a share of assets

0.027%

10th: 0.013%median 0.046%90th: 0.111%

Higher than 26% of the 1,076 plans over $1B that report it.

Source

= $307,150 / $1,157,120,940
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20251013100826NAL0002358578001, received 2025-10-13
assets_eoy: Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20251013100826NAL0002358578001, received 2025-10-13

Employer contributions per participant

$6,702

10th: $1,442median $3,74490th: $8,760

Higher than 81% of the 1,135 plans over $1B that report it.

Source

= $40,949,369 / 6,110
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20251013100826NAL0002358578001, received 2025-10-13
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251013100826NAL0002358578001, received 2025-10-13

Employer share of total contributions

45.6%

10th: 19.8%median 33.4%90th: 47.5%

Higher than 86% of the 1,135 plans over $1B that report it.

Source

= $40,949,369 / $89,826,820
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20251013100826NAL0002358578001, received 2025-10-13
total_contrib: Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20251013100826NAL0002358578001, received 2025-10-13

Plan terms, as stated in Texas Oncology PA's SEC filings

Plan terms are not published in public filings.

Plan features

2A age/service-weighted · 2E profit-sharing · 2F ERISA 404(c) plan · 2G fully participant-directed · 2J 401(k) feature · 2R participant brokerage window · 2T default investment (QDIA) · 3D IRS pre-approved plan · Form 5500, line 8a; TYPE_PENSION_BNFT_CODE pos 81; filing 20251013100826NAL0002358578001, received 2025-10-13

Full record, Texas Oncology, P.A. 401(k) Plan

FieldValueSource
Plan sponsorUS ONCOLOGY CORPORATE, INC.Form 5500, Part II line 2a; SPONSOR_DFE_NAME pos 19; filing 20251013100826NAL0002358578001, received 2025-10-13
Plan nameTEXAS ONCOLOGY, P.A. 401(K) PLANForm 5500, line 1a; PLAN_NAME pos 16; filing 20251013100826NAL0002358578001, received 2025-10-13
Sponsor EIN / plan number75-2131429 / 002Form 5500, line 2b; SPONS_DFE_EIN pos 44; filing 20251013100826NAL0002358578001, received 2025-10-13
Plan typesingle-employerForm 5500, Part I line A; TYPE_PLAN_ENTITY_CD pos 4; filing 20251013100826NAL0002358578001, received 2025-10-13
Sponsor locationDALLAS, TXForm 5500, line 2a; SPONS_DFE_MAIL_US_STATE pos 25; filing 20251013100826NAL0002358578001, received 2025-10-13
Industry (business code)621111, Health care and social assistanceForm 5500, line 2d; BUSINESS_CODE pos 46; filing 20251013100826NAL0002358578001, received 2025-10-13
Plan year2024-01-01 to 2024-12-31Form 5500, Part I plan year; FORM_PLAN_YEAR_BEGIN_DATE pos 2; filing 20251013100826NAL0002358578001, received 2025-10-13
Filing received2025-10-13Form 5500, EFAST2 receipt date; DATE_RECEIVED pos 102; filing 20251013100826NAL0002358578001, received 2025-10-13
Final filingnoForm 5500, Part I line B; FINAL_FILING_IND pos 8; filing 20251013100826NAL0002358578001, received 2025-10-13
Amended filingnoForm 5500, Part I line B; AMENDED_IND pos 7; filing 20251013100826NAL0002358578001, received 2025-10-13
Participants, beginning of year6,267Form 5500, line 5; TOT_PARTCP_BOY_CNT pos 71; filing 20251013100826NAL0002358578001, received 2025-10-13
Active participants4,845Form 5500, line 6a(2); TOT_ACTIVE_PARTCP_CNT pos 72; filing 20251013100826NAL0002358578001, received 2025-10-13
Participants, end of year6,665Form 5500, line 6f; TOT_ACT_RTD_SEP_BENEF_CNT pos 77; filing 20251013100826NAL0002358578001, received 2025-10-13
Participants with an account balance6,110Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251013100826NAL0002358578001, received 2025-10-13
Total assets, beginning of year$985,591,959Schedule H, Part I line 1f col (a); TOT_ASSETS_BOY_AMT pos 30; filing 20251013100826NAL0002358578001, received 2025-10-13
Total assets, end of year$1,157,120,940Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20251013100826NAL0002358578001, received 2025-10-13
Net assets, end of year$1,157,120,940Schedule H, line 1l col (b); NET_ASSETS_EOY_AMT pos 67; filing 20251013100826NAL0002358578001, received 2025-10-13
Total income$252,511,686Schedule H, Part II line 2d; TOT_INCOME_AMT pos 97; filing 20251013100826NAL0002358578001, received 2025-10-13
Net income$171,528,981Schedule H, line 2k; NET_INCOME_AMT pos 111; filing 20251013100826NAL0002358578001, received 2025-10-13
Employer contributions$40,949,369Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20251013100826NAL0002358578001, received 2025-10-13
Participant contributions$38,223,689Schedule H, line 2a(1)(B); PARTICIPANT_CONTRIB_AMT pos 69; filing 20251013100826NAL0002358578001, received 2025-10-13
Other contributions (incl. rollovers)$10,653,762Schedule H, line 2a(1)(C); OTH_CONTRIB_RCVD_AMT pos 70; filing 20251013100826NAL0002358578001, received 2025-10-13
Total contributions$89,826,820Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20251013100826NAL0002358578001, received 2025-10-13
Benefit payments$80,627,088Schedule H, line 2e(4); TOT_DISTRIB_BNFT_AMT pos 101; filing 20251013100826NAL0002358578001, received 2025-10-13
Total expenses (incl. benefit payments)$80,982,705Schedule H, line 2j; TOT_EXPENSES_AMT pos 110; filing 20251013100826NAL0002358578001, received 2025-10-13
Total administrative expenses$307,150Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20251013100826NAL0002358578001, received 2025-10-13
Contract administrator fees$300Schedule H, line 2i(2); CONTRACT_ADMIN_FEES_AMT pos 106; filing 20251013100826NAL0002358578001, received 2025-10-13
Recordkeeping fees$221,120Schedule H, line 2i(3); OTH_RECORDKEEPING_FEES_AMT pos 160; filing 20251013100826NAL0002358578001, received 2025-10-13
IQPA audit fees$14,000Schedule H, line 2i(4); IQPA_AUDIT_FEES_AMT pos 161; filing 20251013100826NAL0002358578001, received 2025-10-13
Investment advisory and management fees$71,730Schedule H, line 2i(5); INVST_MGMT_FEES_AMT pos 107; filing 20251013100826NAL0002358578001, received 2025-10-13
Administrative expenses excluding investment management$235,420derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20251013100826NAL0002358578001, received 2025-10-13
Held in master trusts$0Schedule H, line 1c(11) col (b); INT_MASTER_TR_EOY_AMT pos 53; filing 20251013100826NAL0002358578001, received 2025-10-13
Held in common/collective trusts$968,510,873Schedule H, line 1c(9) col (b); INT_COMMON_TR_EOY_AMT pos 51; filing 20251013100826NAL0002358578001, received 2025-10-13
Held in mutual funds$67,401,970Schedule H, line 1c(13) col (b); INT_REG_INVST_CO_EOY_AMT pos 55; filing 20251013100826NAL0002358578001, received 2025-10-13
Independent auditorMELTON & MELTONSchedule H, Part III line 3a; ACCOUNTANT_FIRM_NAME pos 116; filing 20251013100826NAL0002358578001, received 2025-10-13

Position = column in the DOL layout for form year 2024. Filing 20251013100826NAL0002358578001, received 2025-10-13.

Service providers paid directly by the plan

ProviderRelationshipService codesDirect compensationIndirect
FIDELITY INVESTMENTS INSTITUTIONALrecordkeeperRECORDKEEPER 37 Participant loan processing; 60 Sub-transfer agency fees; 64 Recordkeeping fees; 65 Account maintenance fees; 71 Securities brokerage commissions and fees $239,923yes
NEPC, LLCINVESTMENT ADVISOR 27 Investment advisory (plan); 28 Investment management $71,730no
MELTON AND MELTONACCOUNTANT/AUDITOR 10 Accounting (including auditing) $14,000no

Schedule C Part I line 2: name (a), service codes (b), relationship (c), direct compensation paid by the plan (d), indirect compensation received (e). Filing 20251013100826NAL0002358578001, received 2025-10-13.

What changed since the 2023 plan year

Figure20232024Change
Total assets$985,591,959$1,157,120,94017.4%
Participants with a balance5,6816,1107.6%
Administrative expenses$297,997$307,1503.1%
Recordkeeping fees per participant$34.16$36.196.0%
Employer contributions$37,482,558$40,949,3699.2%

Prior filing 20241014145248NAL0044963968001, received 2024-10-14; the plan years are contiguous.

Alerts, claims and corrections

Alert me when this filing changes

One email when a new Form 5500 for Texas Oncology, P.A. 401(k) Plan appears in the Department of Labor data. Confirmation link first; unsubscribe link in every email.

Claim this plan

For the sponsor or its plan administrator: request to verify or annotate this page. A work email address at the sponsor speeds up verification.

Report a correction

Every figure is reproduced from the filing with its source. Tell us which figure and what the filing says instead.

Sponsor name as filed: US ONCOLOGY CORPORATE, INC.; SEC registrant: TEXAS ONCOLOGY PA (CIK 1008166, matched by EIN).